BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND BCL6, BCL5, 603, 604, ENSG00000113916, ZBTB27, P41182, LAZ3, BCL6A, ZNF51
304 results:

  • 1. Vibration-Controlled Transient Elastography Scores to Predict liver-Related Events in Steatotic liver Disease.
    Lin H; Lee HW; Yip TC; Tsochatzis E; Petta S; Bugianesi E; Yoneda M; Zheng MH; Hagström H; Boursier J; Calleja JL; Goh GB; Chan WK; Gallego-Durán R; Sanyal AJ; de Lédinghen V; Newsome PN; Fan JG; Castéra L; Lai M; Harrison SA; Fournier-Poizat C; Wong GL; Pennisi G; Armandi A; Nakajima A; Liu WY; Shang Y; de Saint-Loup M; Llop E; Teh KK; Lara-Romero C; Asgharpour A; Mahgoub S; Chan MS; Canivet CM; Romero-Gomez M; Kim SU; Wong VW;
    JAMA; 2024 Apr; 331(15):1287-1297. PubMed ID: 38512249
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. OPTN/SRTR 2022 Annual Data Report: liver.
    Kwong AJ; Kim WR; Lake JR; Schladt DP; Schnellinger EM; Gauntt K; McDermott M; Weiss S; Handarova DK; Snyder JJ; Israni AK
    Am J Transplant; 2024 Feb; 24(2S1):S176-S265. PubMed ID: 38431359
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Burden of liver cancer mortality by county, race, and ethnicity in the USA, 2000-19: a systematic analysis of health disparities.
    GBD US Health Disparities Collaborators
    Lancet Public Health; 2024 Mar; 9(3):e186-e198. PubMed ID: 38429018
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19.
    Cao B; Wang Y; Lu H; Huang C; Yang Y; Shang L; Chen Z; Jiang R; Liu Y; Lin L; Peng P; Wang F; Gong F; Hu H; Cheng C; Yao X; Ye X; Zhou H; Shen Y; Liu C; Wang C; Yi Z; Hu B; Xu J; Gu X; Shen J; Xu Y; Zhang L; Fan J; Tang R; Wang C
    N Engl J Med; 2024 Jan; 390(3):230-241. PubMed ID: 38231624
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Feasibility of S-1 adjuvant chemotherapy after major hepatectomy for biliary tract cancers: An exploratory subset analysis of JCOG1202.
    Kobayashi S; Nakachi K; Ikeda M; Konishi M; Ogawa G; Sugiura T; Yanagimoto H; Morinaga S; Wada H; Shimada K; Takahashi Y; Nakagohri T; Kamata K; Shimizu Y; Ajiki T; Hirano S; Gotohda N; Ueno M; Okusaka T; Furuse J
    Eur J Surg Oncol; 2024 Feb; 50(2):107324. PubMed ID: 38157649
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Analysis and prediction of burden of viral hepatitis C-associated diseases in China from 1990 to 2044].
    Zhou M; Yao L; Wu Y; Lin S; Huang J
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2023 Dec; 35(5):476-485. PubMed ID: 38148536
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Incidence and predictors of hepatocellular carcinoma in NAFLD without diagnosed cirrhosis: a nationwide real-world U.S. study.
    Huang DQ; Tran S; Barnett S; Zou B; Yeo YH; Cheung R; Nguyen MH
    Hepatol Int; 2024 Apr; 18(2):540-549. PubMed ID: 38079023
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Beneficial effects of the probiotics and synbiotics supplementation on anthropometric indices and body composition in adults: A systematic review and meta-analysis.
    Saadati S; Naseri K; Asbaghi O; Yousefi M; Golalipour E; de Courten B
    Obes Rev; 2024 Mar; 25(3):e13667. PubMed ID: 38030409
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The independent and joint risks of alcohol consumption, smoking, and excess weight on morbidity and mortality: a systematic review and meta-analysis exploring synergistic associations.
    Burton R; Fryers PT; Sharpe C; Clarke Z; Henn C; Hydes T; Marsden J; Pearce-Smith N; Sheron N
    Public Health; 2024 Jan; 226():39-52. PubMed ID: 38000113
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Evaluation of the Prognostic Role of liver Metastases on Patient Outcomes: Systematic Review and Meta-analysis.
    Waninger JJ; Ma VT; Chopra Z; Pearson AN; Green MD
    Cancer J; 2023 Sep-Oct 01; 29(5):279-284. PubMed ID: 37796646
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. PET/CT imaging fibroblast activation protein in initial colorectal cancer: compared to 18 F-FDG PET/CT.
    Dong Y; Sun P; Wu H; Zhong J; Cao M; Tang G; Zhou W
    Nucl Med Commun; 2023 Nov; 44(11):1011-1019. PubMed ID: 37661771
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Second Primary cancer Among Patients With Papillary Thyroid Carcinoma Following the Chernobyl Disaster.
    Taha A; Taha-Mehlitz S; Nadyrov EA; Zinovkin D; Veyalkin I; Levin L; Pranjol MZI; Melling N; Honaker MD; Cattin PC; Schmid RA
    JAMA Netw Open; 2023 Aug; 6(8):e2329559. PubMed ID: 37589974
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Postoperative Prognosis of Non-alcoholic Fatty liver Disease-Associated Intrahepatic Cholangiocarcinoma: a Multi-center Propensity Score Matching Analysis.
    Yu Q; Lei Z; Ma W; Yang F; Tang H; Xiao Q; Tang X; Si A; Yang P; Zhou N; Cheng Z
    J Gastrointest Surg; 2023 Nov; 27(11):2403-2413. PubMed ID: 37582919
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Age-specific cardiovascular disease-related mortality among patients with major gastrointestinal cancers: A SEER population-based study.
    Liu G; Zhang BF
    Cancer Med; 2023 Aug; 12(16):17253-17265. PubMed ID: 37387603
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Novel models by machine learning to predict prognosis of breast cancer brain metastases.
    Li C; Liu M; Zhang Y; Wang Y; Li J; Sun S; Liu X; Wu H; Feng C; Yao P; Jia Y; Zhang Y; Wei X; Wu F; Du C; Zhao X; Zhang S; Qu J
    J Transl Med; 2023 Jun; 21(1):404. PubMed ID: 37344847
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Optical coherence tomography combined with convolutional neural networks can differentiate between intrahepatic cholangiocarcinoma and liver parenchyma ex vivo.
    Wolff LI; Hachgenei E; Goßmann P; Druzenko M; Frye M; König N; Schmitt RH; Chrysos A; Jöchle K; Truhn D; Kather JN; Lambertz A; Gaisa NT; Jonigk D; Ulmer TF; Neumann UP; Lang SA; Amygdalos I
    J Cancer Res Clin Oncol; 2023 Aug; 149(10):7877-7885. PubMed ID: 37046121
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Positive selection of somatically mutated clones identifies adaptive pathways in metabolic liver disease.
    Wang Z; Zhu S; Jia Y; Wang Y; Kubota N; Fujiwara N; Gordillo R; Lewis C; Zhu M; Sharma T; Li L; Zeng Q; Lin YH; Hsieh MH; Gopal P; Wang T; Hoare M; Campbell P; Hoshida Y; Zhu H
    Cell; 2023 Apr; 186(9):1968-1984.e20. PubMed ID: 37040760
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. TACE-HAIC combined with targeted therapy and immunotherapy versus TACE alone for hepatocellular carcinoma with portal vein tumour thrombus: a propensity score matching study.
    Yuan Y; He W; Yang Z; Qiu J; Huang Z; Shi Y; Lin Z; Zheng Y; Chen M; Lau WY; Li B; Yuan Y
    Int J Surg; 2023 May; 109(5):1222-1230. PubMed ID: 37026861
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Analysis of Characteristics and Risk Factors of Patients with Single Gastric cancer and Synchronous Multiple Gastric cancer among 14,603 Patients.
    Song DH; Kim N; Jo HH; Kim S; Choi Y; Oh HJ; Lee HS; Yoon H; Shin CM; Park YS; Lee DH; Kang SH; Park YS; Ahn SH; Suh YS; Park DJ; Kim HH; Kim JW; Kim JW; Lee KW; Chang W; Park JH; Lee YJ; Lee KH; Kim YH; Ahn S; Surh YJ
    Gut Liver; 2024 Mar; 18(2):231-244. PubMed ID: 36987384
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Laparoscopic modular extended right posterior sectionectomy for hepatocellular carcinoma guided by projection plane extension from the right hepatic vein.
    Lin J; Fang C; Yang J
    J Gastrointest Surg; 2023 Jul; 27(7):1494-1495. PubMed ID: 36932306
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 16.